Chugai Pharmaceutical Co., Ltd. Company Information
Chugai Pharmaceutical Co., Ltd.'s employee growth, exchange listings and data sources
Key Information
- Name: Chugai Pharmaceutical Co., Ltd.
- Ticker: 4519
- Exchange: TSE
- Founded: 1925
- Industry: Pharmaceuticals
- Sector: Pharmaceuticals & Biotech
- Market Cap: JP¥10.943t
- Shares Outstanding: 1.65b
- Website: https://www.chugai-pharm.co.jp
Number of Employees
Location
- Chugai Pharmaceutical Co., Ltd.
- Nihonbashi Mitsui Tower
- Reception12F
- Chuo
- Tokyo
- 103-8324
- Japan
Listings
| Ticker | Exchange | Primary Security | Security Type | Country | Currency | Listed on |
|---|---|---|---|---|---|---|
| 4519 | TSE (The Tokyo Stock Exchange) | Yes | Common Stock | JP | JPY | Jan 1992 |
| CHGC.F | OTCPK (Pink Sheets LLC) | Yes | Common Stock | US | USD | Jan 1992 |
| CUP | DB (Deutsche Boerse AG) | Yes | Common Stock | DE | EUR | Jan 1992 |
| 4519 N | BMV (Bolsa Mexicana de Valores) | Yes | Common Stock | MX | MXN | Jan 1992 |
| CHGC.Y | OTCPK (Pink Sheets LLC) | UNSPN ADS EACH REP 0.5 ORD SHS | US | USD | May 2008 | |
| CUP0 | MUN (Boerse Muenchen) | UNSPN ADS EACH REP 0.5 ORD SHS | DE | EUR | May 2008 | |
| CUP0 | DB (Deutsche Boerse AG) | UNSPN ADS EACH REP 0.5 ORD SHS | DE | EUR | May 2008 |
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/21 05:34 |
| End of Day Share Price | 2024/12/20 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/21 05:34 |
| End of Day Share Price | 2024/12/20 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Chugai Pharmaceutical Co., Ltd. is covered by 29 analysts. 13 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Atsushi Seki | Barclays |
| Koichi Mamegano | BofA Global Research |
| Siti Bte Salikin | CFRA Equity Research |